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AMBILHAR, A NITROTHIAZOLE DERIVATIVE, IN URINARY TRACT BILHARZIA
S. J. POWELL, M.D., F.R.C.P. (EDI .) AND I. . MACLEOD, M.D., F.C.P. (S.A.), M.R.C.P., Amoebiasis Research
Unir and Department of Medicine, University of Natal, Durban
Despite wide usage, reports of the efficacy of antimony
preparations and of the thioxanthones in bilharzia vary
in different regions. The consensus of opinion is, however,
that neither group of drugs provides entirely satisfactory
therapy. Recently the nitrothiazole derivative, Ambilhar-
5-(nitrothiozolyl-[2]-2-oxo-tetrahydro-imidazole)-has been
introduced with encouraging preliminary results. ' Clarke
and Blair' have found it to be effective in Southern
Rhodesia and we now report our findings in an outpatient
trial in Durban.
MATERIAL AND METHODS
One hundred and fifty African and Indian outpatients
attending King Edward VIII Hospital, Durban, with
urinary tract bilharzia, were studied. All complained of
haematuria for periods varying from a few days to several
years. Their ages ranged from 5 to 28 years, although the
majority were in their second decade. Urine specimens
were obtained between 11 a.m. and 1 p.m. and viable ova
of Schistosoma haemarobium were identified before com-
mencing treatment. Quantitative determinations of egg
output were done according to the method of BeW
adapted for S. haematobium.
All patients were given Ambilhar orally in the dosage
of 25 mg./kg. daily in divided doses for 7 days and were
instructed to reattend I and 2 months after completing
treatment.
RESULTS
Cure was assessed as the absence of ova or the presence of
scanty non-viable ova only. Complete follow-up at 2
months could not be obtained as only 90 of the original
150 patients could be traced. At 1 month follow-up 147
patients and at 2 months 87 of the 90 patients, appeared
cured. In all instances the patients stated that their haema-
turia had ceased or was markedly reduced.
Forty-six percent of the patients were found to be
excreting moderate to heavy loads of ova on initial
examination according to Jordan's criteria: but response
to treatment was unrelated to the load of eggs being
excreted.
Apart from 2 patients who complained of abdominal
pain and headache, no intolerance or toxicity was en-
countered.
DISCUSSION
Although to ensure permanent cure of bilharzia it is
desirable to observe patients for 3 months following treat-
ment, this is rarely possible among Indian and African
outpatients. The follow-up attendance of 60% at 2 months
in the present trial is relatively high in our experience. Our
past attempts to assess the efficacy of antimony prepara-
tions and of the thioxanthones have failed owing to
reluctance to reattend hospital because of toxicity, poor
tolerance or failure to relieve symptoms. By contrast,
Ambilhar produced rapid symptomatic relief and was
both easily administered and well tolerated. There were
only two minor instances of intolerance and none of
significant toxicity. The extremely high cure rate of 97%
at 2 months which we report is similar to that found in
preliminary trials elsewhere' and by Clarke and Blair,'
and the results were as satisfactory in patients excreting
heavy loads of eggs as in those with minimal infections.
Ambilhar goes far to meet the need for an effective,
cheap, oral, outpatient remedy for urinary tract bilharzia.
However, caution regarding possible toxicity is still indi-
cated. When a lO-day course of the drug was used in
adult hospital patients with invasive amoebiasis, minor
electrocardiographic changes were frequent, and, in some
instances, confusional mental states, necessitating prompt
cessation of treatment, were of concern: Although we
have not encountered other evidence of significant cardio-
toxicity with Ambilhar alone, when it was given in combi-
nation with dehydroemetine, the electrocardiographic
changes were markedly accentuated: Since antimony pre-
parations are well known to produce similar alterations in
the electrocardiograms, we do not consider that they
should be given simultaneously with Ambilhar and, until
further experience has been gained, it is advisable to allow
some weeks to elapse before administering Ambilhar to
patients who have received antimony compounds. In Natal
bilharzia is predominantly a disease of African and Indian
children and it is probable that among them, provided
care is taken and the correct dosage is adhered to, side-
effects will not be a major problem. evertheless, Ambil-
har is a potent drug and wide usage may result in some
instances of toxicity similar to that encountered in amoe-
biasis, so that plans for indiscriminate and unsupervised
mass treatment should only be approached with caution.
SUMMARY
The results of a trial of Ambilhar in 150 African and Indian
outpatients with urinary tract bilharzia are reported. All but
3 patients appeared cured I month after completing treatment
and cure was maintained in all who could be traced at 2
months. Tolerance was good and no toxicity was encountered.
Ambilhar is a most effective outpatient remedy, but some
caution regarding toxicity is still advisable.
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